Breadcrumbs Skip Navigation LinksGraphene Flagship > Graphene Week > Previous editions > Graphene Week 2019 > Responsible Research and Innovation

Responsible Research and Innovation

14:30, Tuesday, 24 September

On Tuesday 24 September at 14:30, we will hold a session on Responsible Research and Innovation. The discussion will be hosted by the Ethical Advisory Board (EAB) at Graphene Week 2019.

Beginning with insightful and real-world talks from experts, this session will begin with keynote speeches from members of the EAB, Ursula Hohlneicher, Steven Savage and Norberto Patrignani. The EAB was formed to advise the Graphene Flagship on issues relating to ethical standards for research and innovation, which all project members are responsible in upholding.

Join the session on Tuesday 24 September at 14:30 to gain first-hand insight into responsible research and innovation.

Basics of Ethics in Research (Session 1)

The members of the Graphene Flagship Ethics Advisory Board (EAB), Ursula Hohlneicher, Norberto Patrignani and Steven Savage will present the EAB and its objectives and present current thinking on the Basics of Responsible Research and Innovation (RRI). The EAB members will be joined by Richard Fagerström (VTT) in considering the benefits of discussing the potential consequences of technology and scientific advances at an early stage. Engaging relevant stakeholders such as scientists, engineers, manufacturers, policy agencies, and society in a dialogue are key aspects of the RRI concept.

The presenters will share some examples of ethical dilemmas associated with graphene research and will initiate a discussion with the audience.

Ethics Deep Dive (Session 2)

Building on the discussions from the Basics session, the complexity of ethical aspects related to research and how they evolve over time will be discussed with the audience.

We will talk about general considerations about ethics in research such data integrity, publication ethics and the responsibility of each individual to consider their own contribution to the subject. Key elements of RRI will be emphasised. In discussion with the audience we will map RRI stakeholders of graphene research and innovation, and how to engage with them. Then we will present some scenarios and break up in smaller groups to discuss the issues in these scenarios: What are the significant issues and how can these be foreseen, recognised, and managed?


Ursula Hohlneicher, AstraZeneca

Ursula Hohlneicher has worked in senior compliance roles supporting R&D, Manufacturing & Operations, IT and global strategic planning business units at AstraZeneca since 2011. She has a Ph.D. in Chemistry from the University in Cologne; in her more than 20 years with the company she has moved from contributing to drug development as a scientist into project management where here she was responsible for the global implementation of an Electronic Lab Notebook and associated risk management and then into Compliance. In her current role as General Manager Compliance she is responsible for providing leadership and advice related to compliance to the business with a focus on compliance aspects related to interactions with Health Care Professionals and other 3rd parties as well as Bioethics, the use of digital media, risk assessment and different approaches for compliance training.

Steven Savage, FOI - Swedish Defence Research Agency

Steven Savage studied in the UK and graduated with an MSc in chemistry from the University of Salford and a PhD in applied physics from the University of Hull. After moving to Sweden in 1986 he joined the Institute for Metals Research (now part of RISE and SWERIM) and in 1991 joined what is now the Swedish Defence Research Agency. He is today research director (materials), and is involved in a number of different materials-related projects. Along the way he became docent in nanomaterials at The Royal Institute of Technology (KTH).

Steven’s research interests focus on properties, processing and applications of novel materials and technologies for applications ranging from medical implants to weapons systems, and from camouflage to sensors and fall detectors for use in care homes for the elderly. In all these applications ethical questions are important, but are often neglected by the scientists and engineers who design and develop the technology. Because of this approach, ethical problems often become apparent at a relatively advanced stage of development, where it is difficult and expensive to introduce solutions. The results may be sub-optimised and ineffective. For this reason it is important that new technologies based on graphene should be aware of any ethical issues at an early stage, and if possible to design materials and applications which avoid these issues.

Norberto Patrignani, Politecnico di Torino

Norberto Patrignani is Senior Associate Lecturer of "Computer Ethics" at Graduate School of Politecnico di Torino (where collaborates also with I3P, Innovative Enterprise Incubator of the Politecnico di Torino), Associate Lecturer of "ICT & Information Society" at Catholic University of Milano, Expert for the EU Commission - ERC (European Research Council), and Scientific Advisor for Loccioni (Ancona, Italy). He is also the Italian national representative at Technical Committee 9 (TC9) (Relationship between Computers and Society) of the IFIP, International Federation for Information Processing.

Patrignani's interest in taking part in the Graphene Flagship's Ethical Advisory Board is based on his focus on long-term sustainability of ICT, on the ethics and safety of novel technologies, and on the use of a responsible research and innovation approach to developing better research.

Richard Fagerström, VTT

Work experience in the fields of drug discovery, diagnostics and sensor development, molecular biology and industrial microbial production of biomolecules. Of his career about 15 years is work experience in industry R&D and over 20 years in research institutes as e.g. Researcher, Manager, VP Technology, Business Development Manager and Principle Scientist

Fagerström experience has involved lot of ethical issues starting already from his early career in drug discovery followed by genetic engineering issues and thus, it has become a hobby (no formal education in the field). Since 2013 member of the VTT ethical committee performing ethical reviews in human sciences (at VTT) and educating as well as participating in evaluating research ethics and integrity issues. He also participate in domestic research ethics investigations and in events regarding ethics.

Page Contact:
Publishing date: 23 April 2020 12:03